NPI: 1518142710 · KANSAS CITY, MO 64111 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/07/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 01/07/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,563 | $234K |
| 2019 | 14,817 | $233K |
| 2020 | 15,900 | $207K |
| 2021 | 5,552 | $112K |
| 2022 | 1,542 | $54K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,970 | 1,481 | $840K |
| 83550 | 632 | 528 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,273 | 715 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 570 | 400 | $0.00 |
| A4657 | Syringe, with or without needle, each | 1,220 | 1,061 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,172 | 932 | $0.00 |
| 82728 | 707 | 570 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 78 | 67 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 43 | 31 | $0.00 |
| 82607 | 130 | 105 | $0.00 | |
| 90674 | 29 | 18 | $0.00 | |
| 82746 | 62 | 56 | $0.00 | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 12 | 12 | $0.00 |
| 85041 | 722 | 613 | $0.00 | |
| 85048 | 712 | 601 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 2,701 | 556 | $0.00 |
| 83970 | 898 | 730 | $0.00 | |
| 82108 | 62 | 52 | $0.00 | |
| 83540 | 919 | 757 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 402 | 92 | $0.00 |
| 85045 | 60 | 50 | $0.00 |